Health Condition 1: null- Female patients of age between 18 to 65 years, undergoing modified radical mastectomy (MRM) surgery under general anaesthesia.
Conditions
Interventions
Intervention1: Magnesium sulphate as adjuvant to ropivacaine in pectoral nerve block.: Evaluation of analgesic effect of magnesium sulphate as an adjuvant to ropivacaine in pectoral nerve block.
Inter
Sponsors
Dr Harmanpreet Kaur Jhand
Eligibility
Inclusion criteria
Inclusion criteria: American Society of Anaesthesiologistsâ?? Grade I and II patients. Patients of age between 18 to 65 years, undergoing modified radical mastectomy (MRM) surgery under general anaesthesia (GA). Patients willing to give informed written consent.
Exclusion criteria
Exclusion criteria: Patients with any contraindication to regional anesthesia or history of anaphylaxis to local anaesthetics or allergy to the study drugs. ASA-III & ASA-IV patients. Pregnant or lactating patients. Patientâ??s refusal for Pectoral nerve block.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate and compare analgesic effect of magnesium sulphate 150mg as an adjuvant to 0.25% ropivacaine versus 0.25% ropivacaine alone in pectoral nerve block in terms of: Duration of post-operative analgesia. Total analgesic consumption in 24 hours post-operatively.Timepoint: To evaluate and compare analgesic effect of magnesium sulphate 150mg as an adjuvant to 0.25% ropivacaine versus 0.25% ropivacaine alone in pectoral nerve block in terms of: Duration of post-operative analgesia. Total analgesic consumption in 24 hours post-operatively. | — |
Secondary
| Measure | Time frame |
|---|---|
| To record any side effects and patient satisfaction scoreTimepoint: Side effects Patient satisfaction score | — |
Countries
India
Contacts
Public ContactDr Naresh Baghla
GGS Medical College and Hospital, Faridkot
Outcome results
None listed